Gemcitabin Accord 200 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung
7680667350019
CH-66735
Konzentrat
Associated product:
GEMCITABIN Accord 200 mg/2 ml conc perf 1 pce
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
gemcitabinum
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
gemcitabini hydrochloridum
|
- | Substance | WIZUS |
|
macrogolum 300
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
propylenglycolum
|
300.0 MG | Substance | HBESI |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
17.91 MG | Substance | HBESI |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
ethanolum anhydricum
|
880.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 36.85
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2018
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 66735
- Drug name
- Gemcitabin Accord, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01BC05
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 20/08/2018
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- GEMCITABIN Accord 200 mg/2 ml conc perf 1 pce
- Description (DE)
- GEMCITABIN Accord 200 mg/2 ml Konz Inf 1 Stk
- Market launch
- 20/08/2018
- Narcotic (BTM)
- No